Mouse chromosome engineering for modeling human disease.
Chromosomal rearrangements are frequently in humans and can be disease-associated or phenotypically neutral. Recent technological advances have led to the discovery of copy-number changes previously undetected by cytogenetic techniques. To understand the genetic consequences of such genomic changes, these mutations need to be modeled in experimentally tractable systems. The mouse is an excellent organism for this analysis because of its biological and genetic similarity to humans, and the ease with which its genome can be manipulated. Through chromosome engineering, defined rearrangements can be introduced into the mouse genome. The resulting mouse models are leading to a better understanding of the molecular and cellular basis of dosage alterations in human disease phenotypes, in turn opening new diagnostic and therapeutic opportunities.
van der Weyden
Louise
L
Mouse Genomics Lab, Wellcome Trust Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom. lvdw@sanger.ac.uk
Bradley
Allan
A
D000818:Animals; D002875:Chromosomes / Q000235:genetics*; D004195:Disease Models, Animal; D015321:Gene Rearrangement; D005821:Genetic Techniques; D051379:Mice